img

Global Blue Eye Disease Vaccines Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Blue Eye Disease Vaccines Market Insights, Forecast to 2034

PoRV causes a disease commonly referred to as “blue eye disease” because of the corneal opacity seen in some affected pigs
Global Blue Eye Disease Vaccines market is expected to reach to US$ 165.3 million in 2024, with a positive growth of %, compared with US$ 157.5 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Blue Eye Disease Vaccines industry is evaluated to reach US$ 212.8 million in 2029. The CAGR will be 4.3% during 2024 to 2029.
The increasing prevalence of Blue Eye Disease, a viral infection affecting livestock, is driving the demand for vaccines. Factors such as rising awareness about animal health, government initiatives for disease control, and the growing livestock industry contribute to market expansion. Key players in the market are investing in research and development to develop effective and affordable vaccines. Additionally, advancements in biotechnology and vaccine manufacturing processes are expected to propel market growth. However, challenges such as stringent regulations and limited awareness in certain regions may hinder market growth. Overall, the Blue Eye Disease vaccines market is anticipated to witness substantial growth in the foreseeable future.
Report Covers
This report presents an overview of global Blue Eye Disease Vaccines market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Blue Eye Disease Vaccines market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


CAHIC
Boehringer Ingelheim
MSD Animal Health
Chopper Biology
Ceva
Ringpu Biology
Qilu Animal
DHN
Segment by Type
Live Vaccines
Killed Vaccines

Segment by Application


Piglets
Adult Pigs

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
UK
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Blue Eye Disease Vaccines plant distribution, commercial date of Blue Eye Disease Vaccines, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Blue Eye Disease Vaccines introduction, etc. Blue Eye Disease Vaccines Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Blue Eye Disease Vaccines
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Blue Eye Disease Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Blue Eye Disease Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Live Vaccines
1.2.3 Killed Vaccines
1.3 Market by Application
1.3.1 Global Blue Eye Disease Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Piglets
1.3.3 Adult Pigs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Blue Eye Disease Vaccines Sales Estimates and Forecasts 2018-2029
2.2 Global Blue Eye Disease Vaccines Revenue by Region
2.2.1 Global Blue Eye Disease Vaccines Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Blue Eye Disease Vaccines Revenue by Region (2018-2024)
2.2.3 Global Blue Eye Disease Vaccines Revenue by Region (2024-2029)
2.2.4 Global Blue Eye Disease Vaccines Revenue Market Share by Region (2018-2029)
2.3 Global Blue Eye Disease Vaccines Sales Estimates and Forecasts 2018-2029
2.4 Global Blue Eye Disease Vaccines Sales by Region
2.4.1 Global Blue Eye Disease Vaccines Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Blue Eye Disease Vaccines Sales by Region (2018-2024)
2.4.3 Global Blue Eye Disease Vaccines Sales by Region (2024-2029)
2.4.4 Global Blue Eye Disease Vaccines Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Blue Eye Disease Vaccines Sales by Manufacturers
3.1.1 Global Blue Eye Disease Vaccines Sales by Manufacturers (2018-2024)
3.1.2 Global Blue Eye Disease Vaccines Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Blue Eye Disease Vaccines in 2022
3.2 Global Blue Eye Disease Vaccines Revenue by Manufacturers
3.2.1 Global Blue Eye Disease Vaccines Revenue by Manufacturers (2018-2024)
3.2.2 Global Blue Eye Disease Vaccines Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Blue Eye Disease Vaccines Revenue in 2022
3.3 Global Key Players of Blue Eye Disease Vaccines, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Blue Eye Disease Vaccines Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Blue Eye Disease Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Blue Eye Disease Vaccines, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Blue Eye Disease Vaccines, Product Offered and Application
3.8 Global Key Manufacturers of Blue Eye Disease Vaccines, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Blue Eye Disease Vaccines Sales by Type
4.1.1 Global Blue Eye Disease Vaccines Historical Sales by Type (2018-2024)
4.1.2 Global Blue Eye Disease Vaccines Forecasted Sales by Type (2024-2029)
4.1.3 Global Blue Eye Disease Vaccines Sales Market Share by Type (2018-2029)
4.2 Global Blue Eye Disease Vaccines Revenue by Type
4.2.1 Global Blue Eye Disease Vaccines Historical Revenue by Type (2018-2024)
4.2.2 Global Blue Eye Disease Vaccines Forecasted Revenue by Type (2024-2029)
4.2.3 Global Blue Eye Disease Vaccines Revenue Market Share by Type (2018-2029)
4.3 Global Blue Eye Disease Vaccines Price by Type
4.3.1 Global Blue Eye Disease Vaccines Price by Type (2018-2024)
4.3.2 Global Blue Eye Disease Vaccines Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Blue Eye Disease Vaccines Sales by Application
5.1.1 Global Blue Eye Disease Vaccines Historical Sales by Application (2018-2024)
5.1.2 Global Blue Eye Disease Vaccines Forecasted Sales by Application (2024-2029)
5.1.3 Global Blue Eye Disease Vaccines Sales Market Share by Application (2018-2029)
5.2 Global Blue Eye Disease Vaccines Revenue by Application
5.2.1 Global Blue Eye Disease Vaccines Historical Revenue by Application (2018-2024)
5.2.2 Global Blue Eye Disease Vaccines Forecasted Revenue by Application (2024-2029)
5.2.3 Global Blue Eye Disease Vaccines Revenue Market Share by Application (2018-2029)
5.3 Global Blue Eye Disease Vaccines Price by Application
5.3.1 Global Blue Eye Disease Vaccines Price by Application (2018-2024)
5.3.2 Global Blue Eye Disease Vaccines Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Blue Eye Disease Vaccines Market Size by Type
6.1.1 US & Canada Blue Eye Disease Vaccines Sales by Type (2018-2029)
6.1.2 US & Canada Blue Eye Disease Vaccines Revenue by Type (2018-2029)
6.2 US & Canada Blue Eye Disease Vaccines Market Size by Application
6.2.1 US & Canada Blue Eye Disease Vaccines Sales by Application (2018-2029)
6.2.2 US & Canada Blue Eye Disease Vaccines Revenue by Application (2018-2029)
6.3 US & Canada Blue Eye Disease Vaccines Market Size by Country
6.3.1 US & Canada Blue Eye Disease Vaccines Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Blue Eye Disease Vaccines Sales by Country (2018-2029)
6.3.3 US & Canada Blue Eye Disease Vaccines Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Blue Eye Disease Vaccines Market Size by Type
7.1.1 Europe Blue Eye Disease Vaccines Sales by Type (2018-2029)
7.1.2 Europe Blue Eye Disease Vaccines Revenue by Type (2018-2029)
7.2 Europe Blue Eye Disease Vaccines Market Size by Application
7.2.1 Europe Blue Eye Disease Vaccines Sales by Application (2018-2029)
7.2.2 Europe Blue Eye Disease Vaccines Revenue by Application (2018-2029)
7.3 Europe Blue Eye Disease Vaccines Market Size by Country
7.3.1 Europe Blue Eye Disease Vaccines Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Blue Eye Disease Vaccines Sales by Country (2018-2029)
7.3.3 Europe Blue Eye Disease Vaccines Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 UK
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Blue Eye Disease Vaccines Market Size
8.1.1 China Blue Eye Disease Vaccines Sales (2018-2029)
8.1.2 China Blue Eye Disease Vaccines Revenue (2018-2029)
8.2 China Blue Eye Disease Vaccines Market Size by Application
8.2.1 China Blue Eye Disease Vaccines Sales by Application (2018-2029)
8.2.2 China Blue Eye Disease Vaccines Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Blue Eye Disease Vaccines Market Size by Type
9.1.1 Asia Blue Eye Disease Vaccines Sales by Type (2018-2029)
9.1.2 Asia Blue Eye Disease Vaccines Revenue by Type (2018-2029)
9.2 Asia Blue Eye Disease Vaccines Market Size by Application
9.2.1 Asia Blue Eye Disease Vaccines Sales by Application (2018-2029)
9.2.2 Asia Blue Eye Disease Vaccines Revenue by Application (2018-2029)
9.3 Asia Blue Eye Disease Vaccines Sales by Region
9.3.1 Asia Blue Eye Disease Vaccines Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Blue Eye Disease Vaccines Revenue by Region (2018-2029)
9.3.3 Asia Blue Eye Disease Vaccines Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Blue Eye Disease Vaccines Market Size by Type
10.1.1 Middle East, Africa and Latin America Blue Eye Disease Vaccines Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Blue Eye Disease Vaccines Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Blue Eye Disease Vaccines Market Size by Application
10.2.1 Middle East, Africa and Latin America Blue Eye Disease Vaccines Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Blue Eye Disease Vaccines Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Blue Eye Disease Vaccines Sales by Country
10.3.1 Middle East, Africa and Latin America Blue Eye Disease Vaccines Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Blue Eye Disease Vaccines Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Blue Eye Disease Vaccines Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 CAHIC
11.1.1 CAHIC Company Information
11.1.2 CAHIC Overview
11.1.3 CAHIC Blue Eye Disease Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 CAHIC Blue Eye Disease Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 CAHIC Recent Developments
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Information
11.2.2 Boehringer Ingelheim Overview
11.2.3 Boehringer Ingelheim Blue Eye Disease Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Boehringer Ingelheim Blue Eye Disease Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Boehringer Ingelheim Recent Developments
11.3 MSD Animal Health
11.3.1 MSD Animal Health Company Information
11.3.2 MSD Animal Health Overview
11.3.3 MSD Animal Health Blue Eye Disease Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 MSD Animal Health Blue Eye Disease Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 MSD Animal Health Recent Developments
11.4 Chopper Biology
11.4.1 Chopper Biology Company Information
11.4.2 Chopper Biology Overview
11.4.3 Chopper Biology Blue Eye Disease Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Chopper Biology Blue Eye Disease Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Chopper Biology Recent Developments
11.5 Ceva
11.5.1 Ceva Company Information
11.5.2 Ceva Overview
11.5.3 Ceva Blue Eye Disease Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Ceva Blue Eye Disease Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Ceva Recent Developments
11.6 Ringpu Biology
11.6.1 Ringpu Biology Company Information
11.6.2 Ringpu Biology Overview
11.6.3 Ringpu Biology Blue Eye Disease Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Ringpu Biology Blue Eye Disease Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Ringpu Biology Recent Developments
11.7 Qilu Animal
11.7.1 Qilu Animal Company Information
11.7.2 Qilu Animal Overview
11.7.3 Qilu Animal Blue Eye Disease Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Qilu Animal Blue Eye Disease Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Qilu Animal Recent Developments
11.8 DHN
11.8.1 DHN Company Information
11.8.2 DHN Overview
11.8.3 DHN Blue Eye Disease Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 DHN Blue Eye Disease Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 DHN Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Blue Eye Disease Vaccines Industry Chain Analysis
12.2 Blue Eye Disease Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Blue Eye Disease Vaccines Production Mode & Process
12.4 Blue Eye Disease Vaccines Sales and Marketing
12.4.1 Blue Eye Disease Vaccines Sales Channels
12.4.2 Blue Eye Disease Vaccines Distributors
12.5 Blue Eye Disease Vaccines Customers
13 Market Dynamics
13.1 Blue Eye Disease Vaccines Industry Trends
13.2 Blue Eye Disease Vaccines Market Drivers
13.3 Blue Eye Disease Vaccines Market Challenges
13.4 Blue Eye Disease Vaccines Market Restraints
14 Key Findings in The Global Blue Eye Disease Vaccines Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Blue Eye Disease Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Live Vaccines
Table 3. Major Manufacturers of Killed Vaccines
Table 4. Global Blue Eye Disease Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Blue Eye Disease Vaccines Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Blue Eye Disease Vaccines Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Blue Eye Disease Vaccines Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Blue Eye Disease Vaccines Revenue Market Share by Region (2018-2024)
Table 9. Global Blue Eye Disease Vaccines Revenue Market Share by Region (2024-2029)
Table 10. Global Blue Eye Disease Vaccines Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Blue Eye Disease Vaccines Sales by Region (2018-2024) & (M Units)
Table 12. Global Blue Eye Disease Vaccines Sales by Region (2024-2029) & (M Units)
Table 13. Global Blue Eye Disease Vaccines Sales Market Share by Region (2018-2024)
Table 14. Global Blue Eye Disease Vaccines Sales Market Share by Region (2024-2029)
Table 15. Global Blue Eye Disease Vaccines Sales by Manufacturers (2018-2024) & (M Units)
Table 16. Global Blue Eye Disease Vaccines Sales Share by Manufacturers (2018-2024)
Table 17. Global Blue Eye Disease Vaccines Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Blue Eye Disease Vaccines Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Blue Eye Disease Vaccines, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Blue Eye Disease Vaccines Price by Manufacturers 2018-2024 (USD/K Unit)
Table 21. Global Blue Eye Disease Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Blue Eye Disease Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blue Eye Disease Vaccines as of 2022)
Table 23. Global Key Manufacturers of Blue Eye Disease Vaccines, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Blue Eye Disease Vaccines, Product Offered and Application
Table 25. Global Key Manufacturers of Blue Eye Disease Vaccines, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Blue Eye Disease Vaccines Sales by Type (2018-2024) & (M Units)
Table 28. Global Blue Eye Disease Vaccines Sales by Type (2024-2029) & (M Units)
Table 29. Global Blue Eye Disease Vaccines Sales Share by Type (2018-2024)
Table 30. Global Blue Eye Disease Vaccines Sales Share by Type (2024-2029)
Table 31. Global Blue Eye Disease Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Blue Eye Disease Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Blue Eye Disease Vaccines Revenue Share by Type (2018-2024)
Table 34. Global Blue Eye Disease Vaccines Revenue Share by Type (2024-2029)
Table 35. Blue Eye Disease Vaccines Price by Type (2018-2024) & (USD/K Unit)
Table 36. Global Blue Eye Disease Vaccines Price Forecast by Type (2024-2029) & (USD/K Unit)
Table 37. Global Blue Eye Disease Vaccines Sales by Application (2018-2024) & (M Units)
Table 38. Global Blue Eye Disease Vaccines Sales by Application (2024-2029) & (M Units)
Table 39. Global Blue Eye Disease Vaccines Sales Share by Application (2018-2024)
Table 40. Global Blue Eye Disease Vaccines Sales Share by Application (2024-2029)
Table 41. Global Blue Eye Disease Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Blue Eye Disease Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Blue Eye Disease Vaccines Revenue Share by Application (2018-2024)
Table 44. Global Blue Eye Disease Vaccines Revenue Share by Application (2024-2029)
Table 45. Blue Eye Disease Vaccines Price by Application (2018-2024) & (USD/K Unit)
Table 46. Global Blue Eye Disease Vaccines Price Forecast by Application (2024-2029) & (USD/K Unit)
Table 47. US & Canada Blue Eye Disease Vaccines Sales by Type (2018-2024) & (M Units)
Table 48. US & Canada Blue Eye Disease Vaccines Sales by Type (2024-2029) & (M Units)
Table 49. US & Canada Blue Eye Disease Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Blue Eye Disease Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Blue Eye Disease Vaccines Sales by Application (2018-2024) & (M Units)
Table 52. US & Canada Blue Eye Disease Vaccines Sales by Application (2024-2029) & (M Units)
Table 53. US & Canada Blue Eye Disease Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Blue Eye Disease Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Blue Eye Disease Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Blue Eye Disease Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Blue Eye Disease Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Blue Eye Disease Vaccines Sales by Country (2018-2024) & (M Units)
Table 59. US & Canada Blue Eye Disease Vaccines Sales by Country (2024-2029) & (M Units)
Table 60. Europe Blue Eye Disease Vaccines Sales by Type (2018-2024) & (M Units)
Table 61. Europe Blue Eye Disease Vaccines Sales by Type (2024-2029) & (M Units)
Table 62. Europe Blue Eye Disease Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Blue Eye Disease Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Blue Eye Disease Vaccines Sales by Application (2018-2024) & (M Units)
Table 65. Europe Blue Eye Disease Vaccines Sales by Application (2024-2029) & (M Units)
Table 66. Europe Blue Eye Disease Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Blue Eye Disease Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Blue Eye Disease Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Blue Eye Disease Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Blue Eye Disease Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Blue Eye Disease Vaccines Sales by Country (2018-2024) & (M Units)
Table 72. Europe Blue Eye Disease Vaccines Sales by Country (2024-2029) & (M Units)
Table 73. China Blue Eye Disease Vaccines Sales by Type (2018-2024) & (M Units)
Table 74. China Blue Eye Disease Vaccines Sales by Type (2024-2029) & (M Units)
Table 75. China Blue Eye Disease Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Blue Eye Disease Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Blue Eye Disease Vaccines Sales by Application (2018-2024) & (M Units)
Table 78. China Blue Eye Disease Vaccines Sales by Application (2024-2029) & (M Units)
Table 79. China Blue Eye Disease Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Blue Eye Disease Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Blue Eye Disease Vaccines Sales by Type (2018-2024) & (M Units)
Table 82. Asia Blue Eye Disease Vaccines Sales by Type (2024-2029) & (M Units)
Table 83. Asia Blue Eye Disease Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Blue Eye Disease Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Blue Eye Disease Vaccines Sales by Application (2018-2024) & (M Units)
Table 86. Asia Blue Eye Disease Vaccines Sales by Application (2024-2029) & (M Units)
Table 87. Asia Blue Eye Disease Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Blue Eye Disease Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Blue Eye Disease Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Blue Eye Disease Vaccines Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Blue Eye Disease Vaccines Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Blue Eye Disease Vaccines Sales by Region (2018-2024) & (M Units)
Table 93. Asia Blue Eye Disease Vaccines Sales by Region (2024-2029) & (M Units)
Table 94. Middle East, Africa and Latin America Blue Eye Disease Vaccines Sales by Type (2018-2024) & (M Units)
Table 95. Middle East, Africa and Latin America Blue Eye Disease Vaccines Sales by Type (2024-2029) & (M Units)
Table 96. Middle East, Africa and Latin America Blue Eye Disease Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Blue Eye Disease Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Blue Eye Disease Vaccines Sales by Application (2018-2024) & (M Units)
Table 99. Middle East, Africa and Latin America Blue Eye Disease Vaccines Sales by Application (2024-2029) & (M Units)
Table 100. Middle East, Africa and Latin America Blue Eye Disease Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Blue Eye Disease Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Blue Eye Disease Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Blue Eye Disease Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Blue Eye Disease Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Blue Eye Disease Vaccines Sales by Country (2018-2024) & (M Units)
Table 106. Middle East, Africa and Latin America Blue Eye Disease Vaccines Sales by Country (2024-2029) & (M Units)
Table 107. CAHIC Company Information
Table 108. CAHIC Description and Major Businesses
Table 109. CAHIC Blue Eye Disease Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 110. CAHIC Blue Eye Disease Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. CAHIC Recent Developments
Table 112. Boehringer Ingelheim Company Information
Table 113. Boehringer Ingelheim Description and Major Businesses
Table 114. Boehringer Ingelheim Blue Eye Disease Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 115. Boehringer Ingelheim Blue Eye Disease Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Boehringer Ingelheim Recent Developments
Table 117. MSD Animal Health Company Information
Table 118. MSD Animal Health Description and Major Businesses
Table 119. MSD Animal Health Blue Eye Disease Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 120. MSD Animal Health Blue Eye Disease Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. MSD Animal Health Recent Developments
Table 122. Chopper Biology Company Information
Table 123. Chopper Biology Description and Major Businesses
Table 124. Chopper Biology Blue Eye Disease Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 125. Chopper Biology Blue Eye Disease Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Chopper Biology Recent Developments
Table 127. Ceva Company Information
Table 128. Ceva Description and Major Businesses
Table 129. Ceva Blue Eye Disease Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 130. Ceva Blue Eye Disease Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Ceva Recent Developments
Table 132. Ringpu Biology Company Information
Table 133. Ringpu Biology Description and Major Businesses
Table 134. Ringpu Biology Blue Eye Disease Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 135. Ringpu Biology Blue Eye Disease Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Ringpu Biology Recent Developments
Table 137. Qilu Animal Company Information
Table 138. Qilu Animal Description and Major Businesses
Table 139. Qilu Animal Blue Eye Disease Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 140. Qilu Animal Blue Eye Disease Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Qilu Animal Recent Developments
Table 142. DHN Company Information
Table 143. DHN Description and Major Businesses
Table 144. DHN Blue Eye Disease Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 145. DHN Blue Eye Disease Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. DHN Recent Developments
Table 147. Key Raw Materials Lists
Table 148. Raw Materials Key Suppliers Lists
Table 149. Blue Eye Disease Vaccines Distributors List
Table 150. Blue Eye Disease Vaccines Customers List
Table 151. Blue Eye Disease Vaccines Market Trends
Table 152. Blue Eye Disease Vaccines Market Drivers
Table 153. Blue Eye Disease Vaccines Market Challenges
Table 154. Blue Eye Disease Vaccines Market Restraints
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Blue Eye Disease Vaccines Product Picture
Figure 2. Global Blue Eye Disease Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Blue Eye Disease Vaccines Market Share by Type in 2022 & 2029
Figure 4. Live Vaccines Product Picture
Figure 5. Killed Vaccines Product Picture
Figure 6. Global Blue Eye Disease Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Blue Eye Disease Vaccines Market Share by Application in 2022 & 2029
Figure 8. Piglets
Figure 9. Adult Pigs
Figure 10. Blue Eye Disease Vaccines Report Years Considered
Figure 11. Global Blue Eye Disease Vaccines Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Blue Eye Disease Vaccines Revenue 2018-2029 (US$ Million)
Figure 13. Global Blue Eye Disease Vaccines Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 14. Global Blue Eye Disease Vaccines Revenue Market Share by Region (2018-2029)
Figure 15. Global Blue Eye Disease Vaccines Sales 2018-2029 ((M Units)
Figure 16. Global Blue Eye Disease Vaccines Sales Market Share by Region (2018-2029)
Figure 17. US & Canada Blue Eye Disease Vaccines Sales YoY (2018-2029) & (M Units)
Figure 18. US & Canada Blue Eye Disease Vaccines Revenue YoY (2018-2029) & (US$ Million)
Figure 19. Europe Blue Eye Disease Vaccines Sales YoY (2018-2029) & (M Units)
Figure 20. Europe Blue Eye Disease Vaccines Revenue YoY (2018-2029) & (US$ Million)
Figure 21. China Blue Eye Disease Vaccines Sales YoY (2018-2029) & (M Units)
Figure 22. China Blue Eye Disease Vaccines Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Asia (excluding China) Blue Eye Disease Vaccines Sales YoY (2018-2029) & (M Units)
Figure 24. Asia (excluding China) Blue Eye Disease Vaccines Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Blue Eye Disease Vaccines Sales YoY (2018-2029) & (M Units)
Figure 26. Middle East, Africa and Latin America Blue Eye Disease Vaccines Revenue YoY (2018-2029) & (US$ Million)
Figure 27. The Blue Eye Disease Vaccines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 28. The Top 5 and 10 Largest Manufacturers of Blue Eye Disease Vaccines in the World: Market Share by Blue Eye Disease Vaccines Revenue in 2022
Figure 29. Global Blue Eye Disease Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Global Blue Eye Disease Vaccines Sales Market Share by Type (2018-2029)
Figure 31. Global Blue Eye Disease Vaccines Revenue Market Share by Type (2018-2029)
Figure 32. Global Blue Eye Disease Vaccines Sales Market Share by Application (2018-2029)
Figure 33. Global Blue Eye Disease Vaccines Revenue Market Share by Application (2018-2029)
Figure 34. US & Canada Blue Eye Disease Vaccines Sales Market Share by Type (2018-2029)
Figure 35. US & Canada Blue Eye Disease Vaccines Revenue Market Share by Type (2018-2029)
Figure 36. US & Canada Blue Eye Disease Vaccines Sales Market Share by Application (2018-2029)
Figure 37. US & Canada Blue Eye Disease Vaccines Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Blue Eye Disease Vaccines Revenue Share by Country (2018-2029)
Figure 39. US & Canada Blue Eye Disease Vaccines Sales Share by Country (2018-2029)
Figure 40. U.S. Blue Eye Disease Vaccines Revenue (2018-2029) & (US$ Million)
Figure 41. Canada Blue Eye Disease Vaccines Revenue (2018-2029) & (US$ Million)
Figure 42. Europe Blue Eye Disease Vaccines Sales Market Share by Type (2018-2029)
Figure 43. Europe Blue Eye Disease Vaccines Revenue Market Share by Type (2018-2029)
Figure 44. Europe Blue Eye Disease Vaccines Sales Market Share by Application (2018-2029)
Figure 45. Europe Blue Eye Disease Vaccines Revenue Market Share by Application (2018-2029)
Figure 46. Europe Blue Eye Disease Vaccines Revenue Share by Country (2018-2029)
Figure 47. Europe Blue Eye Disease Vaccines Sales Share by Country (2018-2029)
Figure 48. Germany Blue Eye Disease Vaccines Revenue (2018-2029) & (US$ Million)
Figure 49. France Blue Eye Disease Vaccines Revenue (2018-2029) & (US$ Million)
Figure 50. UK Blue Eye Disease Vaccines Revenue (2018-2029) & (US$ Million)
Figure 51. Italy Blue Eye Disease Vaccines Revenue (2018-2029) & (US$ Million)
Figure 52. Russia Blue Eye Disease Vaccines Revenue (2018-2029) & (US$ Million)
Figure 53. China Blue Eye Disease Vaccines Sales Market Share by Type (2018-2029)
Figure 54. China Blue Eye Disease Vaccines Revenue Market Share by Type (2018-2029)
Figure 55. China Blue Eye Disease Vaccines Sales Market Share by Application (2018-2029)
Figure 56. China Blue Eye Disease Vaccines Revenue Market Share by Application (2018-2029)
Figure 57. Asia Blue Eye Disease Vaccines Sales Market Share by Type (2018-2029)
Figure 58. Asia Blue Eye Disease Vaccines Revenue Market Share by Type (2018-2029)
Figure 59. Asia Blue Eye Disease Vaccines Sales Market Share by Application (2018-2029)
Figure 60. Asia Blue Eye Disease Vaccines Revenue Market Share by Application (2018-2029)
Figure 61. Asia Blue Eye Disease Vaccines Revenue Share by Region (2018-2029)
Figure 62. Asia Blue Eye Disease Vaccines Sales Share by Region (2018-2029)
Figure 63. Japan Blue Eye Disease Vaccines Revenue (2018-2029) & (US$ Million)
Figure 64. South Korea Blue Eye Disease Vaccines Revenue (2018-2029) & (US$ Million)
Figure 65. China Taiwan Blue Eye Disease Vaccines Revenue (2018-2029) & (US$ Million)
Figure 66. Southeast Asia Blue Eye Disease Vaccines Revenue (2018-2029) & (US$ Million)
Figure 67. India Blue Eye Disease Vaccines Revenue (2018-2029) & (US$ Million)
Figure 68. Middle East, Africa and Latin America Blue Eye Disease Vaccines Sales Market Share by Type (2018-2029)
Figure 69. Middle East, Africa and Latin America Blue Eye Disease Vaccines Revenue Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Blue Eye Disease Vaccines Sales Market Share by Application (2018-2029)
Figure 71. Middle East, Africa and Latin America Blue Eye Disease Vaccines Revenue Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Blue Eye Disease Vaccines Revenue Share by Country (2018-2029)
Figure 73. Middle East, Africa and Latin America Blue Eye Disease Vaccines Sales Share by Country (2018-2029)
Figure 74. Brazil Blue Eye Disease Vaccines Revenue (2018-2029) & (US$ Million)
Figure 75. Mexico Blue Eye Disease Vaccines Revenue (2018-2029) & (US$ Million)
Figure 76. Turkey Blue Eye Disease Vaccines Revenue (2018-2029) & (US$ Million)
Figure 77. Israel Blue Eye Disease Vaccines Revenue (2018-2029) & (US$ Million)
Figure 78. GCC Countries Blue Eye Disease Vaccines Revenue (2018-2029) & (US$ Million)
Figure 79. Blue Eye Disease Vaccines Value Chain
Figure 80. Blue Eye Disease Vaccines Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries